The White House and industry leaders say shipping companies are moving goods faster ahead of the holidays, President Joe Biden extends the pause on federal student loan repayment, and the FDA authorizes the Pfizer COVID-19 pill for emergency use.
FDA Authorizes Pfizer’s COVID-19 Pill After Securing $5 Billion Deal With Federal Government
The Food and Drug Administration (FDA) on Wednesday granted emergency use authorization to Pfizer’s COVID-19 treatment pill. The pill, Paxlovid, is taken twice per day for five days in combination with a second medicine called ritonavir, classified as a generic antiviral drug. The drug is aimed at helping patients who are suffering from “mild-to-moderate” COVID-19 from becoming so sick…
FDA Authorizes Pfizer’s COVID-19 Pill Weeks After Landing $5 Billion Deal With Biden Administration
The Food and Drug Administration (FDA) on Wednesday granted emergency use authorization to Pfizer’s COVID-19 treatment pill—coming about a month after the federal government announced it would purchase 10 million courses of the drug. The pill, Paxlovid, is taken twice per day for five days in combination with a second medicine called ritonavir, classified as a generic antiviral…
Pfizer to Provide 2.5 Million Additional Doses of Its COVID-19 Pill to UK
Pfizer Inc. said on Wednesday it will provide an additional 2.5 million doses of its COVID-19 pill Paxlovid to the United Kingdom. A total of 2.75 million doses of the pill are expected to be delivered to the UK through 2022, the drugmaker said.
Western Australia First State to Mandate Vaccine Boosters
December 22, 2021
admin
AustraliaboosterCCP Virusmark mcgowanModernaPfizervaccinationVaccines & SafetyWestern AustraliaWorld
0 Comment
Western Australia (WA) has become the first jurisdiction in Australia to mandate a third COVID-19 booster shot for its workers. The state was one of the first to implement sweeping vaccination mandates, with 75 percent of WA’s workforce—more than one million workers—needing to be double dosed by February next year. Those workers will now be…
Live Q&A: NY Law Could Allow the ‘Indefinite Detention’ of Unvaccinated; Virus Becoming “Endemic”
New York Bill A416 would give government powers to detain indefinitely anyone deemed a “significant threat to public health.” Meanwhile, Pfizer executives are now claiming that COVID-19 could become endemic by 2024. In other words, the virus is likely here to stay. So does this mean the social control policies are also here to stay?…
Pfizer Says Its Low-Dose Vaccine Doesn’t Work in Kids Aged 2–5
A low dose of the Pfizer-BioNTech COVID-19 vaccine didn’t produce a significant immune response among children between the ages of 2 and 5, the two firms said on Friday. Amid clinical trials that are ongoing, the two drugmakers tested 3 micrograms of the vaccine in kids aged 6 months to less than 5 years of age….
Eight Cases of Heart Inflammation Reported Among Kids Ages 5–11 Years Who Received Pfizer and BioNTech’s COVID-19 Vaccine: CDC
Eight cases of myocarditis, a type of heart inflammation, have been reported in children aged 5–11 years who received Pfizer and BioNTech’s COVID-19 vaccine, officials from the U.S. Centers for Disease Control and Prevention (CDC) said on Dec. 16. The CDC Vaccine Advisory Panel spoke via an online meeting Thursday to discuss the Johnson & Johnson coronavirus vaccine…
Eight Cases of Heart Inflammation Reported Among Kids 5–11 Who Received Pfizer COVID-19 Vaccine: CDC
Eight cases of myocarditis, a type of heart inflammation, have been reported in children aged 5–11 years who received Pfizer and BioNTech’s COVID-19 vaccine, officials from the U.S. Centers for Disease Control and Prevention (CDC) said on Dec. 16. The CDC Vaccine Advisory Panel spoke via an online meeting Thursday to discuss the Johnson & Johnson coronavirus vaccine…
Pfizer and BioNTech File for Full FDA Approval of Vaccine in Ages 12-15
Vaccine manufacturers Pfizer and BioNTech have submitted an application to the Food and Drug Administration (FDA) seeking to expand the approval of their COVID-19 shots to individuals aged between 12 and 15, citing trial data, the company announced on Thursday. In a statement, the companies said their application to the FDA includes updated longer-term follow-up data from their…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`